Page 22 - Intelligence Analysis News Today

The uveitis market is expected to increase owing to the increasing awareness, improved diagnosis, and rising diagnosed prevalent population. In addition, the expected launch of emerging therapies

The obstructive sleep apnea market dynamics are anticipated to change in the coming years owing to the expected approval of emerging therapies focused on treating obstructive sleep apnea during

/PRNewswire/ -- DelveInsights Glioma Market Insights report includes a comprehensive understanding of current treatment practices, glioma emerging drugs,...

The expected launch of therapies by several pharma companies such as ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others

/PRNewswire/ -- DelveInsights Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic...

The opioid use disorder market is expected to grow in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading companies such

/PRNewswire/ -- DelveInsights Opioid Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, opioid use...

/PRNewswire/ -- DelveInsights FAK Inhibitors Competitive Landscape report delivers an in-depth understanding of the FAK inhibitors and the FAK inhibitors...

The dynamics of the FAK inhibitor market is anticipated to change as companies across the globe are thoroughly working toward developing new FAK options with convenient RoA and better safety

Next-generation immunotherapies market is expected to grow significantly during the forecast period (2023-2032) owing to the increasing number of cancer cases in the 7MM, accompanied by the